|Podcasts|November 1, 2021
Addressing Implicit Bias in Oncology Nursing
Author(s)Lindsay Fischer
“It is not a ‘one and done kind of thing.” It is very important to implement these skills throughout the community. It's a practice. It's a behavioral change.”
Advertisement
For this episode of “The Vitals,” Oncology Nursing News spoke with Gretchen McNally, APRN-CNP, and Kathy Burns, MS, APRN-CNS, AGCNS-BC, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, on the importance of being mindful about one’s implicit bias in the treatment of patients with cancer who have substance use disorders.
Advertisement
Related to this article
Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinic workflows, safety checks, and at-home dosing potential for on-body isatuximab.
Discover how equine-assisted services support patients with cancer by improving emotional wellness, building confidence, and enhancing quality of life.
Two Winship nurses explain how to talk with breast cancer survivors about GLP-1 receptor agonists, from endocrine therapy to access barriers.
ABUS matched handheld ultrasound on cancer detection in women with dense breasts while lowering recall and short-interval follow-up rates.
A Moffitt nurse practitioner explains rollout, handling, triage, and patient education for nogapendekin alfa inbakicept-pmln plus BCG.
Life table analysis estimates residual ovarian cancer risk by current age and planned age at risk-reducing surgery.
Nogapendekin alfa inbakicept-pmln plus BCG now covers high-grade papillary-only disease, based on extrapolation from CIS efficacy data.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Delaying BSO to Age 50 Leaves BRCA1 Carriers With 24% Ovarian Cancer Risk
2
FDA Expands Anktiva Approval to Papillary-Only BCG-Unresponsive NMIBC
3
Automated Breast Ultrasound Tied to Fewer False-Positives in Dense Breasts
4
GLP-1s After Breast Cancer: What Nurses Should Ask Survivors
5